JOLYN PELOUS: Open Payments
NPI 1528658275 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 18 payments from 14 companies in 2025. Trend: 2023 $336 · 2024 $216 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $100 |
| Actelion Pharmaceuticals US, Inc. | 3 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Boston Scientific Corporation | 1 | $26 |
| Contego Medical, Inc | 1 | $22 |
| Novo Nordisk Inc | 1 | $22 |
| Amgen Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
Products named: LEQVIO, VERQUVO, UPTRAVI, WATCHMAN FLX, Wegovy, REPATHA, OPSYNVI, Dexcom G6 Transmitter.
Industry payments across LA — which companies pay providers there.
